Related Experiment Video

Updated: Mar 15, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.8K

Vascular Disease in Young Indians (20-40 years): Role of Dyslipidemia

Jamshed Dalal1, Pradeep Kumar Deb2, Sameer Shrivastava3

  • 1Director, Centre for Cardiac Sciences, Kokilaben Dhirubhai Ambani Hospital , Mumbai, India .

Journal of Clinical and Diagnostic Research : JCDR
|September 16, 2016
PubMed

Insights

Dyslipidemia, a risk factor for cardiovascular disease, affects young Indians. This review covers prevalence, guidelines, and expert insights for managing dyslipidemia in individuals aged 20-40.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Dyslipidemia is a significant risk factor for cardiovascular disease (CVD).
  • Early signs of atherosclerosis, like fatty streaks, are present in young adults.
  • Premature coronary heart disease (CHD) risk is elevated in the Indian population.

Purpose of the Study:

  • To review the prevalence of dyslipidemia in young Indians (20-40 years).
  • To examine current guidelines for managing dyslipidemia in this demographic.
  • To provide expert commentary on the challenges and strategies for dyslipidemia management in young Indians.

Main Methods:

  • Literature review of dyslipidemia prevalence studies in young Indians.
  • Analysis of existing national and international guidelines relevant to young adults.
  • Compilation of expert opinions and recommendations on clinical management.

Main Results:

  • High prevalence of dyslipidemia noted in the young Indian population.
  • Current guidelines may require adaptation for the specific needs of young Indians.
  • Challenges in diagnosis and treatment adherence identified.

Conclusions:

  • Early screening and intervention for dyslipidemia are crucial in young Indians.
  • Tailored management strategies are needed to address the unique risk factors and challenges.
  • Further research is warranted to optimize dyslipidemia care for this age group.

Keywords:
DietEpidemiologyManagement

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
558
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
794
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
740
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.8K